IBJNews

Blockbuster deal: Eli Lilly paying $5.4B for Novartis Animal Health

Back to TopCommentsE-mailPrintBookmark and Share

Eli Lilly and Co. has agreed to pay $5.4 billion in cash for Novartis Animal Health in the second-largest deal in the company's history. The acquisition from Switzerland-based Novartis is part of a blockbuster three-way drug deal that also includes United Kingdom-based GlaxoSmithKline.

Indianapolis-based Lilly plans to fold the $1.1-billion-in-revenue Novartis Animal Health into its Greenfield-based Elanco division, making it the world's second-largest animal health company by revenue. Novartis Animal Health has more than 3,000 employees, nine manufacturing sites and 600 products, with another 40 in development, Lilly said in an early morning statement announcing the deal.

The deal is the second largest for Lilly, behind the company's $6.5 billion purchase of ImClone Systems in 2008.

The sale is part of a series of transactions announced early Tuesday by Novartis, which agreed to acquire GlaxoSmithKline's oncology products for $14.5 billion while selling GSK its vaccines business for $7.1 billion plus royalties.

Lilly plans to finance its purchase with $3.4 billion in cash on hand and borrowings of $2 billion. The company anticipates $200 million in annual savings and said the acquisition should add to earnings by 2016. Novartis Animal Health is focused on prevention and treatment of disease in pets, farm animals and farmed fish.

"Animal health continues to represent an attractive growth opportunity for Lilly. We intend to keep Elanco and to take advantage of the substantial synergies between our animal health and human health businesses," Eli Lilly CEO John Lechleiter said in a prepared statement.

The deal is scheduled to close by the end of the first quarter of 2015.

Elanco is nearly twice as large as the Novartis animal health unit, with 2013 sales of nearly $2.2 billion. Revenue at Elanco has doubled since 2008.

The company has achieved much of that growth through smaller acquisitions, most notably the 2008 purchase of the controversial bovine growth hormone rbST from St. Louis-based Monsanto Co.

Earlier this year, Elanco agreed to buy Germany-based Lohmann Animal Health for an undisclosed price, which gave it poultry vaccines and manufacturing facilities.

Elanco also has built up a business for pets, including a version of its iconic antidepressant Prozac for dogs. Pets, or companion animal health, is Novartis’ strength, with those products accounting for 49 percent of its revenue.

Lechleiter frequently has cited Elanco as a growth engine that can help offset the loss of revenue stemming from 2011 patent expirations on its $5-billion-a-year antipsychotic Zyprexa and the 2013 and 2014 patent expirations on its $5-billion-a-year antidepressant Cymbalta.

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. Can your dog sign a marriage license or personally state that he wishes to join you in a legal union? If not then no, you cannot marry him. When you teach him to read, write, and speak a discernible language, then maybe you'll have a reasonable argument. Thanks for playing!

  2. Look no further than Mike Rowe, the former host of dirty jobs, who was also a classically trained singer.

  3. Current law states income taxes are paid to the county of residence not county of income source. The most likely scenario would be some alteration of the income tax distribution formula so money earned in Marion co. would go to Marion Co by residents of other counties would partially be distributed to Marion co. as opposed to now where the entirety is held by the resident's county.

  4. This is more same-old, same-old from a new generation of non-progressive 'progressives and fear mongers. One only needs to look at the economic havoc being experienced in California to understand the effect of drought on economies and people's lives. The same mindset in California turned a blind eye to the growth of population and water needs in California, defeating proposal after proposal to build reservoirs, improve water storage and delivery infrastructure...and the price now being paid for putting the demands of a raucous minority ahead of the needs of many. Some people never, never learn..

  5. I wonder if I can marry him too? Considering we are both males, wouldn't that be a same sex marriage as well? If they don't honor it, I'll scream discrimination just like all these people have....

ADVERTISEMENT